Lei Feng
-
- Diabetes Management and Research 5
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
-
- Cardiovascular Function and Risk Factors 6
-
- Adipokines, Inflammation, and Metabolic Diseases 3
-
- Cardiac Imaging and Diagnostics 4
-
- Lipoproteins and Cardiovascular Health 4
- Coronary Interventions and Diagnostics 4
Lei Feng
38 papers receiving 433 citations
Peers
Comparison fields: 5 of 87
- Endocrinology, Diabetes and Metabolism 181
- Cardiology and Cardiovascular Medicine 127
- Critical Care and Intensive Care Medicine 14
- Epidemiology 87
- Sensory Systems 11
Countries citing papers authored by Lei Feng
This map shows the geographic impact of Lei Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Feng more than expected).
Fields of papers citing papers by Lei Feng
This network shows the impact of papers produced by Lei Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Feng. The network helps show where Lei Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 37 | |
| 10 | 2023 | 23 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 55 | |
| 14 | 2018 | 18 | |
| 15 | 2018 | 5 | |
| 16 | 2014 | 7 | |
| 17 | 2014 | 25 | |
| 18 | 2014 | 13 | |
| 19 | 2014 | 17 | |
| 20 | 2013 | 11 |
About Lei Feng
Lei Feng is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Anesthesiology and Pain Medicine, having authored 43 papers that have together received 439 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (6 papers), Diabetes Management and Research (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers), Cardiac Imaging and Diagnostics (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Coronary Interventions and Diagnostics (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (181 citations), Cardiology and Cardiovascular Medicine (127 citations) and Critical Care and Intensive Care Medicine (14 citations). Lei Feng has collaborated with scholars based in China, United States and Colombia. Frequent co-authors include Xuejing Bai, Xuan Luo, Mengna Wu, Kefei Dou, Cheng‐Gang Zhu, Kongyong Cui, Dong Yin, Weihua Song, Xuan Yang and Rui Fu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.